Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: B.D. who wrote (27383)	1/12/1999 7:52:00 PM
From: medsunman	Read Replies (2) \| Respond to of 32384

BD: Sorry, I don't know why it takes so long to analyze data, but it seems to take quite a while in almost every case. Perhaps someone more familiar with the process can answer your question.

To: B.D. who wrote (27383)	1/13/1999 1:46:00 AM
From: aknahow	Read Replies (1) \| Respond to of 32384

B.D. don't laugh but I have been told, that the hold up in releasing the results to shareholders comes in large part not from a delay in the analysis but in finding a scientific forum or publication in which to first release the results. I believe this is really the case. One can imagine certain types of scientist, with certain types of egos that have worked hard to develop a drug and design trials being against a dumbed down report to shareholders before they get their place in the sun. I believe this is correct because I believe your post is correct. There is no doubt companies know the results long before they find their suitable forums. Perhaps someday these companies will figure out that shareholders are also a suitable forum for first release.

To: B.D. who wrote (27383)	1/14/1999 9:18:00 PM
From: carl w. trygstad	Respond to of 32384

There are a number of things that need to happen after the last patient is finished with the trial before the sponsor knows if the drug is effective. These include data checks to be sure the data from the source and case report forms are valid, creation and checking the data against edit specs and entry of the data into a validated data base. This all usually takes several months. Only after that can the data base be "locked" and only then can it be determined if the trial drug was effective. The entire process must follow FDA guidelines which although time consuming help to ensure validity. Fortunately, the days when we could do data analysis with pens and a calculator are long gone.